Essential Strategies For Gene Therapy - From Assay Development To CDx Commercialization
Source: Precision ADVANCE
Innovators developing gene therapies face a multitude of challenges, from the lab to the FDA. Yet a number of successful strategies are emerging that are mitigating the risks, reducing costs and smoothing out the road to approval. Listen to a panel of gene therapy experts with unique perspectives and real-world experiences share successful approaches in gene therapy development, CDx development and commercialization.
Attendees Will Hear:
- Factors in the NAb vs. TAb assay choice, including respective assay development challenges and agency outlooks
- How to make the most of early engagement and collaboration with regulatory agencies
- How to plan and prepare for CDx development from the beginning of assay development
- New approaches for CDx regulatory approval and commercialization
VIEW THE WEBINAR!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Precision ADVANCE
This website uses cookies to ensure you get the best experience on our website. Learn more